Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Amant

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Human Brain Mapping|August 21, 2010
Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patientsSabine Deprez, Frederic Amant, Refika Yigit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
In utero exposure to chemotherapy: effect on cardiac and neurologic outcomeKristel Van Calsteren, Patrick Berteloot, Myriam Hanssens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 5, 2013
Synchronous ovarian and endometrial cancer--an international multicenter case-control studyFlorian Heitz, Frederic Amant, Christina Fotopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, et al.
Plos One|February 2, 2012
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancerPaul H van der Horst, Yongyi Wang, Ingrid Vandenput, et al.
The Lancet. Haematology|December 22, 2015
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle studyPeter Vandenberghe, Iwona Wlodarska, Thomas Tousseyn, et al.
JAMA Oncology|August 7, 2015
Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant PatientsSibylle Loibl, André Schmidt, Oreste Gentilini, et al.
Elife|August 3, 2014
Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaksHui Zhao, Bernard Thienpont, Betül Tuba Yesilyurt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECTStephen Chia, William Gradishar, Louis Mauriac, et al.
Cancer Discovery|September 4, 2014
Patient-derived xenograft models: an emerging platform for translational cancer researchManuel Hidalgo, Frederic Amant, Andrew V Biankin, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Human Brain Mapping|August 21, 2010
Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patientsSabine Deprez, Frederic Amant, Refika Yigit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
In utero exposure to chemotherapy: effect on cardiac and neurologic outcomeKristel Van Calsteren, Patrick Berteloot, Myriam Hanssens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 5, 2013
Synchronous ovarian and endometrial cancer--an international multicenter case-control studyFlorian Heitz, Frederic Amant, Christina Fotopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, et al.
Plos One|February 2, 2012
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancerPaul H van der Horst, Yongyi Wang, Ingrid Vandenput, et al.
The Lancet. Haematology|December 22, 2015
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle studyPeter Vandenberghe, Iwona Wlodarska, Thomas Tousseyn, et al.
JAMA Oncology|August 7, 2015
Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant PatientsSibylle Loibl, André Schmidt, Oreste Gentilini, et al.
Elife|August 3, 2014
Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaksHui Zhao, Bernard Thienpont, Betül Tuba Yesilyurt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECTStephen Chia, William Gradishar, Louis Mauriac, et al.
Cancer Discovery|September 4, 2014
Patient-derived xenograft models: an emerging platform for translational cancer researchManuel Hidalgo, Frederic Amant, Andrew V Biankin, et al.
Pageof 18